Media releases are provided as is by companies and have not been edited or checked for accuracy. Any queries should be directed to the company itself.
  • 24 December 2019 17:22

Global CNS Digital Therapeutics Market - Key Players, SWOT Analysis, Dynamics, Drivers and Forecasts by 2030

According to the report, the CNS digital therapeutics market is estimated to be over US$ 737.5 Mn in 2018. It is anticipated to grow at a 31.6% CAGR from 2019 to 2030.

The updated research report on the CNS digital therapeutics market delivers essential information on market share, size, and growth rate for the forecast period 2019 - 2030. Subject matter experts have divided the CNS digital therapeutics market into several categories like product, technology, application, end user, and geography. They have provided deep insights on each of these segments to provide the operating players with information to expand their business and increase their clientele in the near future. The report further elaborates crucial information on major driving factors that are expected to propel the CNS digital therapeutics market by the end of 2030. Major challenges are also systematically mentioned for the players to take every profit-maximizing step carefully.

Get FREE Sample Copy with TOC to understand the structure of the complete report

The report also explains strengths, weaknesses, opportunities, and threats for the industry players to systematically plan their strategies and gain topmost position among competitors. The study aims at providing real-time information to the players, such as current market trends, developments in the industry, import and export status, consumer buying behavior, and more.

Key Players:

The prominent players in the CNS digital therapeutics market are Pear Therapeutics, Inc., Dthera Sciences, Akili Interactive Labs, Inc, Epicadence, CLICK THERAPEUTICS, INC., Cognoa, GAIA AG, MindSciences, Brainmarc and MedRhythms among others.

The rising prevalence of neurological diseases is on among the major factors driving the growth of CNS digital therapeutics market. According to Alzheimer organization, alzheimer’s disease  is one among the most expensive disease, the treatment expenditure is higher compared to that for treatment of several cancers. Though there is no definite cure available for alzheimer disease, digital therapeutics here can play a pivotal role in helping in treatment of such neurological disease in a cost effective way compared to the conventional medicines.

Submit a media release